AngioDynamics (NSDQ:ANGO) shares are up a tad today after the medical device company beat Wall Street’s expectations with its fiscal 2nd-quarter earnings.
Wall Street Beat
London’s Lombard Medical seeks U.S. IPO
Hologic faces another activist investor
St. Jude Medical soars to new heights
Medical device giant St. Jude Medical (NYSE:STJ) ended 2013 with a boost, notching a new Wall Street high-water mark of $63.15 on December 26.
Boston Scientific puts more skin in China
Boston Scientific (NYSE:BSX) is looking to stimulate its China division through a series of acquisitions and a workforce boost that the medtech giant hopes will help it claim a bigger part of the Chinese market.
Short-seller takes another shot at Mindray Medical
Short-seller Ottoman Bay Research took another shot at Mindray Medical (NYSE:MR) this week, taking issue with the Chinese medical device company’s response to Ottoman’s initial accusations of fraud and mismanagement.
Next year looks good for IPOs
Initial public offerings hit decade-long highs in 2013, a trend that should continue in 2014, according to Renaissance Capital.
Coming off of their best year since 2000, U.S. IPOs should fare well in the new year, based on "a building backlog of IPOs and economic indicators continuing to show signs of improvement," according to the IPO investment advisor.
2013: Medtech’s banner year
The medtech industry had a banner year in 2013, with share prices for some 39 publicly traded medical device makers rising an average 44.8% as of Dec. 17, outpacing the Dow Jones Industrial Average (up 21.1% this year), the S&P 500 (+24.9%) and the NASDAQ index (+29.8%).